Table 2.
Treatment-related clinical response and superior vena cava (SVC) flow
SVC flow (mL/kg/min) |
T-DSM-IV-S (score) |
||||||||
---|---|---|---|---|---|---|---|---|---|
Before MPH | 15th day of MPH treatment | p | Before MPH |
30th day of MPH treatment |
|||||
I | H/I | Total score | I | H/I | Total score | ||||
Effective initial treatment (N=15) | 80.5±27.3 | 69.2±27.8 | <0.001 | 19.7±4.1 | 17.8±4.0 | 37.6±3.7 | 9.2±1.8 | 8.5±1.8 | 17.7±1.9 |
Ineffective initial treatment (N=2) | |||||||||
Patient no. 1 | 63.8 | 63.1 | 20 | 18 | 38 | 16 | 13 | 29 | |
Patient no. 2 | 46.2 | 49.2 | 18 | 18 | 36 | 14 | 13 | 27 |
Values are presented as mean±standard deviation or mean. T-DSM-IV-S, Turgay Diagnostic and Statistical Manual of Mental Disorders-IVBased Child and Adolescent Behavioural Disorders Screening and Rating Scale; MPH, methylphenidate; I, inattention; H/I, hyperactivity/impulsiveness